Safety information / evidence gaps
KPV
FDA has not identified human exposure data for KPV drug products.
No dosing or purchase guidance. This information is not a recommendation to use a compound.
Keep the safety limits visible.
FDA says it has not identified human exposure data for drug products containing KPV administered through any route.
The agency lacks important information about safety issues, including whether administration to humans would cause harm. That uncertainty must not be reframed as reassurance.
A source discussing safety gaps does not prove a gut-health, skin or anti-inflammatory treatment benefit. This page provides no dosing instructions, efficacy promise or seller links.
Original source
Interpretation is limited to the source linked above. Independent medical review pending.